Lipopolysaccharide (LPS) from Burkholderia cepacia is more active than LPS from Pseudomonas aeruginosa and Stenotrophomonas maltophilia in stimulating tumor necrosis factor alpha from human monocytes

Infection and Immunity

Volumn 67, Issue 3, 1999, Pages 1505-1507

  Zughaier, Susu M ^a   Ryley, Henry C ^a   Jackson, Simon K ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CD14 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; CYTOKINE PRODUCTION; ESCHERICHIA COLI; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS MALTOPHILIA;

EID: 0033015044     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.67.3.1505-1507.1999     Document Type: Article

References (13)

1. Denton, M. 1997. Stenotrophomonas maltophilia: an emerging problem in cystic fibrosis patients. Rev. Med. Microbiol. 8:15-19.
2. Galanos, C., O. Luderitz, and O. Westphal. 1969. A new method for the extraction of R-lipopolysaccharide. Eur. J. Biochem. 9:245-249.
3. Goldman, D. A., and J. D. Klinger. 1986. Pseudomonas cepacia: biology, mechanisms of virulence, epidemiology. J. Pediatr. 108:806-812.
4. Govan, J. R. W., P. H. Brown, J. Maddison, et al. 1993. Evidence of transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 342:15-19.
5. Govan, J. R. W., J. E. Hughes, and P. Vandamme. 1998. Burkholderia cepacia: medical, taxonomic and ecological issues. J. Med. Microbiol. 45:395-407.
6. Govan, J. R. W., and J. W. Nelson. 1992. Microbiology of lung infection in cystic fibrosis. Br. Med. Bull. 48:912-930.
7. Greally, P., M. J. Hussein, A. J. Cook, A. P. Sampson, P. J. Piper, and J. F. Price. 1993. Sputum tumor necrosis factor-α and leukotriene concentrations in cystic fibrosis. Arch. Dis. Child. 68:389-392.
8. Lancet. June 6, 1992. Pseudomonas cepacia - more than a harmless commensal? Lancet 339:1385-1386. (Editorial.)
9. Lipuma, J. J., S. E. Dasen, D. W. Neilson, R. C. Stern, and T. L. Stull. 1990. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 336:527-532.
10. Prince, A. 1986. Antibiotic resistance of Pseudomonas species. J. Pediatr. 108:830-834.
11. Riestschel, E.-T., L. Brade, B. Lindner, and U. Zahringer. 1992. Biochemistry of lipopolysaccharides, p. 3-41. In D. C. Morrison and J. L. Ryan (ed.), Bacterial endotoxic lipopolysaccharides. CRC Press. Inc., Boca Raton, Fla.
12. Shaw, D., I. R. Poxton, and J. R. W. Govan. 1995. Biological activity of Burkholderia (Pseudomonas) cepacia lipopolysaccharide. FEMS Immunol. Med. Microbiol. 11:99-106.
13. Watanabe, N., K. Nakada, and Y. Kobayashi. 1998. Processing and release of tumor necrosis factor α. Eur. J. Biochem. 253:576-582.